Bulletin
Investor Alert

Sotera Health Co.

NAS: SHC

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Sotera Health Co.

After Hours

 --Quotes are delayed by 20 min

Feb 3, 2023, 4:15 p.m.

SHC
/zigman2/quotes/222596028/composite

$

18.15

Change

0.00 0.00%

Volume

Volume 15,881

Quotes are delayed by 20 min

/zigman2/quotes/222596028/composite

Previous close

$ 18.68

$ 18.15

Change

-0.53 -2.84%

Day low

Day high

$17.79

$18.50

Open

52 week low

52 week high

$5.78

$24.90

Open

Company Description

Sotera Health Co. provides mission-critical sterilization, lab testing and advisory services to the medical device and pharmaceutical industries. It also provides end-to-end sterilization as well as microbiological and analytical lab testing and advisory services to help ensure that medical, pharmac...

Sotera Health Co. provides mission-critical sterilization, lab testing and advisory services to the medical device and pharmaceutical industries. It also provides end-to-end sterilization as well as microbiological and analytical lab testing and advisory services to help ensure that medical, pharmaceutical and food products are safe for healthcare practitioners, patients and consumers. The firm operates through the following businesses: Sterigenics, Nordion, and Nelson Labs. The Sterigenics business provides outsourced terminal sterilization and irradiation services for the medical device, pharmaceutical, food safety and advanced applications markets by using following technologies: gamma irradiation, EO processing and E-beam irradiation. The Nordion business provides Co-60 and gamma irradiators, which are the key components to the gamma sterilization process. The Nelson Labs business provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries. The company was founded in 1978 and is headquartered in Broadview Heights, OH.

Valuation

P/E Current

45.24

P/E Ratio (with extraordinary items)

43.31

P/E Ratio (without extraordinary items)

57.04

Price to Sales Ratio

7.06

Price to Book Ratio

11.37

Price to Cash Flow Ratio

23.95

Enterprise Value to EBITDA

15.41

Enterprise Value to Sales

7.04

Efficiency

Total Asset Turnover

0.34

Liquidity

Current Ratio

2.15

Quick Ratio

1.79

Cash Ratio

0.66

Profitability

Gross Margin

48.84

Operating Margin

32.25

Pretax Margin

18.86

Net Margin

12.38

Return on Assets

4.16

Return on Equity

22.22

Return on Total Capital

12.54

Capital Structure

Total Debt to Total Assets

65.53

Officers and Executives

Name Age Officer Since Title
Mr. Michael B. Petras 52 2016 Chairman & Chief Executive Officer
Mr. Michael Francis Biehl 65 2022 Chief Financial Officer
Mr. Robert G. Hauzie - 2019 Chief Information Officer
Mr. Michael P. Rutz 48 2020 President-Sterigenics
Mr. Kurt M. Roth - 2015 Senior VP-Corporate Development & Strategy

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
11/20/2022 Michael B. Petras
Chairman & CEO; Director 		29,251   Derivative/Non-derivative trans. at $6.02 per share. 176,091
11/20/2022 Michael P. Rutz
President of Sterigenics 		1,911   Derivative/Non-derivative trans. at $6.02 per share. 11,504
11/07/2022 Alexander Dimitrief
SVP, General Counsel and Sec. 		235,478   Award at $0 per share. 0
05/27/2022 Ann R. Klee
Director 		10,643   Award at $0 per share. 0
05/27/2022 Vincent Kevin Petrella
Director 		10,643   Award at $0 per share. 0
05/27/2022 Dave Anthony Donnini
Director 		10,643   Award at $0 per share. 0
05/27/2022 Dean Spyro Mihas
Director 		10,643   Award at $0 per share. 0
05/27/2022 Sean Laurence Cunningham
Director 		10,643   Award at $0 per share. 0
05/27/2022 James C. Neary
Director 		10,643   Award at $0 per share. 0
05/27/2022 Ruoxi Chen
Director 		10,643   Award at $0 per share. 0
05/27/2022 Stephanie M. Geveda
Director 		10,643   Award at $0 per share. 0
05/27/2022 David E. Wheadon
Director 		10,643   Award at $0 per share. 0
03/02/2022 Michael B. Petras
Chairman & CEO; Director 		187,219   Award at $0 per share. 0
03/02/2022 Scott J. Leffler
CFO and Treasurer 		37,443   Award at $0 per share. 0
03/02/2022 Michael P. Rutz
President of Sterigenics 		24,962   Award at $0 per share. 0
03/02/2022 Terrence G. Hammons
SVP, GC and Secretary 		22,466   Award at $0 per share. 0
11/20/2021 Michael B. Petras
Chairman & CEO; Director 		27,517   Derivative/Non-derivative trans. at $22.54 per share. 620,233
11/20/2021 Scott J. Leffler
CFO and Treasurer 		3,894   Derivative/Non-derivative trans. at $22.54 per share. 87,770
11/20/2021 Michael P. Rutz
President of Sterigenics 		1,911   Derivative/Non-derivative trans. at $22.54 per share. 43,073
11/11/2021 Terrence G. Hammons
SVP, GC and Secretary 		8,791   Award at $0 per share. 0
08/25/2021 Michael P. Rutz
President of Sterigenics 		67,000   Disposition at $25.03 per share. 1,677,010
05/28/2021 Ann R. Klee
Director 		9,336   Award at $0 per share. 0
05/28/2021 Vincent Kevin Petrella
Director 		9,336   Award at $0 per share. 0
05/28/2021 Dave Anthony Donnini
Director 		9,336   Award at $0 per share. 0
05/28/2021 Dean Spyro Mihas
Director 		9,336   Award at $0 per share. 0
05/28/2021 Sean Laurence Cunningham
Director 		9,336   Award at $0 per share. 0
05/28/2021 James C. Neary
Director 		9,336   Award at $0 per share. 0
05/28/2021 Ruoxi Chen
Director 		9,336   Award at $0 per share. 0
05/28/2021 Stephanie M. Geveda
Director 		9,336   Award at $0 per share. 0
05/28/2021 David E. Wheadon
Director 		9,336   Award at $0 per share. 0
03/22/2021 Warburg Pincus LLC
Director 		13,512,582   Disposition at $26.12 per share. 352,948,641
03/22/2021 Warburg Pincus LLC
Director 		13,512,582   Disposition at $26.12 per share. 352,948,641
03/22/2021 GTCR LLC
Director 		9,008,388   Disposition at $26.12 per share. 235,299,094
03/22/2021 Michael B. Petras
Chairman & CEO; Director 		817,439   Disposition at $26.12 per share. 21,351,506
03/22/2021 Matthew J. Klaben
Interim SVP, GC and Secretary 		41,952   Disposition at $26.12 per share. 1,095,786
11/24/2020 Michael B. Petras
Chairman & CEO; Director 		946,102   20,511,491
11/24/2020 Michael B. Petras
Chairman & CEO; Director 		437,821   9,491,959
11/24/2020 Scott J. Leffler
CFO and Treasurer 		115,326   2,500,267
11/24/2020 Matthew J. Klaben
Interim SVP, GC and Secretary 		69,196   1,500,169
/news/latest/company/us/shc

MarketWatch News on SHC

  2. Sotera Health upgraded to neutral from underweight at J.P. Morgan

    6:32 a.m. Jan. 23, 2023

    - Tomi Kilgore

  3. Compass Pitches 5% Yield Today, Growth Tomorrow

    10:26 p.m. Jan. 20, 2023

    - Barron's Online

  5. Compass Has a Growth Pitch but Investors Are Wary

    4:26 p.m. Nov. 3, 2022

    - Barron's Online

  6. Sotera Health downgraded to sector weight from overweight at KeyBanc Capital

    5:07 a.m. Sept. 26, 2022

    - Tomi Kilgore

  7. Sotera Health double downgraded to underweight from overweight at J.P. Morgan

    5:43 a.m. Sept. 21, 2022

    - Tomi Kilgore

  8. Inflation Ran Hot in December. 15 Stocks to Help Tame It.

    8:56 a.m. Jan. 12, 2022

    - Barron's Online

  9. Sotera Health started at overweight with $35 stock price target at J.P. Morgan

    8:24 a.m. Dec. 15, 2020

    - Tomi Kilgore

  10. Stocks end the week on a downbeat as rising COVID cases weigh

    4:27 p.m. Nov. 20, 2020

    - Mark DeCambre

  11. Maravai LifeSciences Jumps Nearly 19% in IPO. Sotera Pops 17%.

    1:33 p.m. Nov. 20, 2020

    - Barron's Online

  13. Sotera Health's stock opens at $27.00, or 17% above IPO price

    12:04 p.m. Nov. 20, 2020

    - Tomi Kilgore

  14. Sotera Health's stock now indicated to open around $26.15, or 13.7% above the IPO price

    11:10 a.m. Nov. 20, 2020

    - Tomi Kilgore

  15. Sotera Health's stock indicated to open around $25.20, or 9.6% above the $23 IPO price

    10:42 a.m. Nov. 20, 2020

    - Tomi Kilgore

  18. Sotera Health sets IPO terms, to offer 46.6 mln shares priced at $20 to $23 each

    6:52 a.m. Nov. 12, 2020

    - Ciara Linnane

/news/nonmarketwatch/company/us/shc

Other News on SHC

  2. Sotera Health Company (SHC) Q3 2022 Earnings Call Transcript

    1:52 p.m. Nov. 5, 2022

    - Seeking Alpha

  3. 10-Q: SOTERA HEALTH CO

    3:44 p.m. Nov. 2, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  6. Sotera Health: Litigation Looms Large

    11:22 a.m. Nov. 1, 2022

    - Seeking Alpha

  8. The 1-Minute Market Report October 2, 2022

    2:40 p.m. Oct. 3, 2022

    - Seeking Alpha

  9. Warning: SHC is at high risk of performing badly

    2:56 a.m. Sept. 26, 2022

    - Seeking Alpha

  13. Why Sotera Health Stock Tumbled Again on Tuesday

    3:50 p.m. Sept. 20, 2022

    - Motley Fool

  14. BLUE, TUSK and TRVI among mid-day movers

    12:54 p.m. Sept. 20, 2022

    - Seeking Alpha

  16. Why Sotera Health Stock Crumbled Today

    4:30 p.m. Sept. 19, 2022

    - Motley Fool

  20. Warburg Pincus Partner Stephanie Geveda to Launch New Firm

    12:18 p.m. Sept. 9, 2022

    - The Wall Street Journal Interactive Edition

  21. Loading more headlines...

At a Glance

Sotera Health Co.

9100 South Hills Boulevard

Suite 300

Broadview Heights, Ohio 44147-3518

Phone

1 4402621410

Industry

Medical Equipment/Supplies

Sector

Health Care/Life Sciences

Fiscal Year-end

12/2022

View SEC Filings

Revenue

$931.48M

Net Income

$115.36M

Employees

3,000

Annual Report for SHC

/news/pressrelease/company/us/shc

Press Releases on SHC

  21. Loading more headlines...
Link to MarketWatch's Slice.